HighTower Advisors, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$504,000
+142.3%
5,930
+1.0%
0.00%
+100.0%
Q2 2020$208,000
-62.5%
5,871
-85.8%
0.00%
-75.0%
Q1 2020$554,000
-37.1%
41,207
-1.3%
0.00%
-20.0%
Q4 2019$881,000
+63.8%
41,729
+3.3%
0.01%
+66.7%
Q3 2019$538,000
-7.7%
40,386
-4.0%
0.00%0.0%
Q2 2019$583,000
-29.2%
42,048
-1.8%
0.00%
-40.0%
Q1 2019$823,000
+23.4%
42,830
-8.3%
0.01%0.0%
Q4 2018$667,000
-30.8%
46,730
+0.7%
0.01%
-28.6%
Q3 2018$964,000
-8.5%
46,423
+4.2%
0.01%
-12.5%
Q2 2018$1,054,000
+33.4%
44,549
-17.7%
0.01%
+14.3%
Q1 2018$790,000
-6.0%
54,150
+4.4%
0.01%0.0%
Q4 2017$840,000
+15.5%
51,865
+0.1%
0.01%
+16.7%
Q3 2017$727,000
+55.0%
51,815
-2.3%
0.01%
+50.0%
Q2 2017$469,000
+25.1%
53,060
-8.7%
0.00%0.0%
Q1 2017$375,000
+100.5%
58,115
+13.8%
0.00%
+100.0%
Q4 2016$187,000
+3.9%
51,065
-6.2%
0.00%0.0%
Q3 2016$180,000
+41.7%
54,465
+1.1%
0.00%0.0%
Q2 2016$127,000
-17.0%
53,865
-10.7%
0.00%
Q1 2016$153,000
-16.8%
60,3150.0%0.00%
-100.0%
Q4 2015$184,000
+76.9%
60,315
+0.6%
0.00%
+100.0%
Q3 2015$104,000
-49.5%
59,965
+18.1%
0.00%
-66.7%
Q2 2015$206,00050,7650.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders